Cargando…
Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
BACKGROUND: Breast cancer is the leading cause of cancer-related mortality in women worldwide. Long non-coding RNAs (lncRNAs) are of critical importance in tumor drug resistance. Herein, this study aims to determine the roles of lncRNA ZEB1-AS1 in drug resistance of breast cancer involving microRNA-...
Autores principales: | Gao, Jin, Yuan, Yuan, Zhang, Lili, Yu, Shaorong, Lu, Jianwei, Feng, Jifeng, Hu, Sainan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092489/ https://www.ncbi.nlm.nih.gov/pubmed/32210737 http://dx.doi.org/10.1186/s12935-020-1164-8 |
Ejemplares similares
-
Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
por: Gao, Jin, et al.
Publicado: (2021) -
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
por: Kim, Taewan, et al.
Publicado: (2011) -
The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial–mesenchymal transition
por: Xiong, Yaoyao, et al.
Publicado: (2021) -
Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
por: Wu, Ziping, et al.
Publicado: (2019) -
ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression
por: Ma, Ming-Hui, et al.
Publicado: (2019)